Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03637959 · ClinicalTrials.gov registry record · NA

Liver Fibrosis Evaluation Using Ultrasound Shear Wave Imaging

A NA study of Liver Fibrosis, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
270
Enrollment target
1
Study location

NCT03637959 is a NA study of Liver Fibrosis that has completed, run by Mayo Clinic. The registered enrollment target is 270 participants, below the 349-participant average among 11 other Liver Fibrosis trials with a reported enrollment target (23% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03637959, a NA study of Liver Fibrosis, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
270 participants
Enrollment target
1
Study location

Study Summary

The Researchers are trying to assess the effectiveness of a new ultrasound technique for non-invasive evaluation of liver fibrosis.

Conditions Studied

Interventions

  • DEVICE Mechanical Vibrations with Ultrasound Shear Wave Imaging

Study Locations (1)

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 270 participants
Start Date 2017-01-26
Est. Completion 2020-11-04
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT03637959

The ClinicalTrials.gov registry entry for NCT03637959 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 270 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 349-participant average among 11 other Liver Fibrosis trials with a reported enrollment target (23% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Liver Fibrosis appearing as the primary indexed condition, and to 1 intervention - of which Mechanical Vibrations with Ultrasound Shear Wave Imaging is the first listed.

NCT03637959 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT03637959 about?

NCT03637959 is a clinical study titled "Liver Fibrosis Evaluation Using Ultrasound Shear Wave Imaging". The Researchers are trying to assess the effectiveness of a new ultrasound technique for non-invasive evaluation of liver fibrosis.

What is the current status of trial NCT03637959?

This trial is currently completed. It is a NA study. The enrollment target is 270 participants. The study started on 2017-01-26. Estimated completion is 2020-11-04.

What conditions does trial NCT03637959 study?

This clinical trial studies the following conditions: Liver Fibrosis.

What interventions are being tested in trial NCT03637959?

The interventions under investigation include: Mechanical Vibrations with Ultrasound Shear Wave Imaging (DEVICE).

Who is sponsoring clinical trial NCT03637959?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03637959 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Liver Fibrosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.